Francis S. Collins, M.D., Ph.D., currently serves as an NIH Distinguished Investigator in the intramural program of the National Human Genome Research Institute, pursuing genomics research on type 2 diabetes and a rare disorder of premature aging called progeria.
Dr. Collins is a physician-geneticist noted for his landmark discoveries of disease genes and his previous leadership of the international Human Genome Project, which culminated in April 2003 with the completion of a finished sequence of the human DNA instruction book. He served as director of the National Human Genome Research Institute at NIH from 1993-2008.
Dr. Collins then served as the 16th Director of the National Institutes of Health (NIH), appointed by President Barack Obama and confirmed by the Senate in 2009. In 2017, President Donald Trump asked Dr. Collins to continue to serve as the NIH Director. President Joe Biden did the same in 2021. For those 12 years, serving an unprecedented three administrations, Dr. Collins oversaw the work of the largest supporter of biomedical research in the world, spanning the spectrum from basic to clinical research. Dr. Collins stepped down as NIH Director on December 19, 2021.
From February 2022 to October 2022, Dr. Collins served as Acting Science Advisor to President Biden. From November 2022 to May 2023 he continued his White House service as a Special Advisor to the President for Special Projects. He continues to serve as the White House lead for a bold program to eliminate hepatitis C in the United States.
Dr. Collins is an elected member of both the National Academy of Medicine and the National Academy of Sciences, was awarded the Presidential Medal of Freedom in November 2007, and received the National Medal of Science in 2009. In 2020, he was elected as a Foreign Member of the Royal Society (UK) and was also named the 50th winner of the Templeton Prize, which celebrates scientific and spiritual curiosity.
W. Kimryn Rathmell, M.D., Ph.D., M.M.H.C., was sworn in as the 17th NCI director on December 18, 2023. She previously led the Vanderbilt University Medical Center as physician-in-chief and chair of the Department of Medicine.
Dr. Rathmell is a recipient of the 2019 Louisa Nelson Award for Women of Achievement, Vision, and Inspiration, the 2019 Eugene P. Schonfeld Award from the Kidney Cancer Association, and the Paragon Award for Research Excellence from the Doris Duke Foundation. She was a leader of The Cancer Genome Atlas’s (TCGA) kidney cancer projects and served as a TCGA analysis working group member across the spectrum of cancers, winning the 2020 American Association for Cancer Research Team Science Award. She has served on the NCI Board of Scientific Advisors, and the Forbeck Foundation Scientific Advisory Board.
Dr. Rathmell has held leadership positions with the American Society of Clinical Oncology and the American Society for Clinical Investigation, serving as secretary–treasurer and president. As a result of her efforts, Dr. Rathmell has been elected to the Association of American Physicians, the American Academy of Arts and Sciences, and the National Academy of Medicine.
Dr. Rathmell’s specialty is the research and treatment of complex and hereditary kidney cancers. She also focuses on underlying drivers of kidney cancers using genetic, molecular, and cell biology to develop interventions to improve patients’ lives. Dr. Rathmell’s research has resulted in more than 250 articles in leading peer-reviewed journals, including The New England Journal of Medicine, Nature, Proceedings of the National Academy of Sciences, and the Journal of Clinical Investigation.
Dr. Rathmell earned undergraduate degrees in biology and chemistry from the University of Northern Iowa and her Ph.D. in biophysics and M.D. from Stanford University. She completed an internal medicine internship at the University of Chicago and an internal medicine residency, medical oncology fellowship, and postdoctoral studies at the University of Pennsylvania. In 2022, she completed her Master of Management in Health Care from the Vanderbilt University Owen Graduate School of Management.
James J. DiCarlo M.D., Ph.D.
Peter de Florez Professor of Neuroscience Director, MIT Quest for Intelligence
Co-Director, Center for Brains, Minds, and Machines Investigator, McGovern Institute for Brain Research Massachusetts Institute of Technology
Jim DiCarlo is a Professor of Systems and Computational Neuroscience at the Massachusetts Institute of Technology. His research team’s primary goal is to discover and artificially emulate the brain mechanisms that underlie human visual intelligence. Over the past 20 years, using the non-human primate animal model organism, DiCarlo and his collaborators have helped develop our contemporary, engineering-level understanding of the neural mechanisms that underlie visual information processing in the ventral visual stream — a complex series of interconnected brains areas — and how that processing supports core cognitive abilities such as object and face recognition. He and his collaborators aim to use this newly emerging scientific understanding to guide the development of more robust artificial vision systems (“AI”), to reveal new ways to beneficially modulate brain activity via modulations of images striking our eyes, to expose new methods of accelerating visual learning, to provide a basis for new neural prosthetics (brain-machine interfaces) to restore lost senses, and to provide a scientific foundation to understand how sensory processing is altered in conditions such as agnosia, autism and dyslexia.
DiCarlo trained in biomedical engineering, medicine, systems neurophysiology and computing at Northwestern (BSE), Johns Hopkins (MD/PhD), and Baylor College of Medicine (Postdoc). He served as Head of MIT’s Department of Brain and Cognitive Sciences from 2012 to 2021, and he is currently the Director of the MIT Quest for Intelligence (2021-present) where he and his leadership team are working to advance interdisciplinary research at the interface of natural and artificial intelligence. DiCarlo is an Alfred P. Sloan Research Fellow, a Pew Scholar in Biomedical Sciences, a McKnight Scholar in Neuroscience, and an elected member of the American Academy of Arts & Sciences.
TIME | EVENT | LOCATION |
9:30 AM – 12:30 PM | Registration | Atrium |
12:30 PM – 2:00 PM | Lunch Keynote Speaker: Dr. Rathmell | Elevation Ballroom |
2:00 PM – 3:00 PM | Oral Presentations: Immunology & Microbiology General Medicine & Physiology | Elevation Ballroom Blue Spruce/Aspen |
3:00 PM – 3:30 PM | Coffee Break | Atrium |
3:30 PM – 4:30 PM | DEI: Dr. Hamblin Ethics: Dr. Hyun (Session A) | DEI: Elevation Ballroom Ethics: Blue Spruce/Aspen |
4:45 PM – 5:45 PM | Career Panel | Elevation Ballroom |
5:45 PM – 7:15 PM | Dinner Keynote Speaker: Dr. DiCarlo | Elevation Ballroom |
7:15 PM – 7:30 PM | Poster set up | Forest/Atrium |
7:30 PM – 9:00 PM | Poster Session I & Happy Hour Sponsored by FAER | Forest/Atrium |
TIME | EVENT | LOCATION |
7:30 AM – 8:30 AM | Breakfast | Elevation Ballroom |
8:30 AM – 11:30 AM | Funday Activities | Various |
11:30 PM – 12:30 PM | Lunch PSTP Networking | Elevation Ballroom |
12:45 PM – 2:00 PM | Internal Medicine PSTP Panel Pediatrics/Anesthesia/Pathology PSTP Panel | Elevation Ballroom Blue Spruce/Aspen |
2:00 PM – 3:00 PM | Keynote: Dr. Brenner | Elevation Ballroom |
3:00 PM – 3:30 PM | ASPA Presentation | Elevation Ballroom |
3:30 PM – 4:00 PM | Coffee Break | Atrium |
4:00 PM – 5:00 PM | DEI: Dr. Hamblin Ethics: Dr. Hyun (Session B) | DEI: Blue Spruce/Aspen Ethics: Elevation Ballroom |
5:15 PM – 6:45 PM | Poster Session II & Happy Hour Sponsored by the Department of Pathology, CU Anschutz Medical Campus | Forest/Atrium |
7:00 PM – 9:00 PM | Dinner Keynote Speaker: Dr. Collins | Elevation Ballroom |
TIME | EVENT | LOCATION |
8:30 AM – 9:30 AM | Breakfast | Elevation Ballroom |
9:30 AM – 10:30 AM | Oral Presentations: Bioengineering & Medical Imaging Cancer Biology | Blue Spruce/Aspen Elevation Ballroom |
10:45 AM – 11:45 AM | Oral Presentations: Neuroscience Molecular Biology & Pharmacology | Blue Spruce/Aspen Elevation Ballroom |
12:00 PM – 1:00 PM | Lunch & Closing Remarks | Elevation Ballroom |